Leading National Fertility Clinic Network and Global Family-Building Benefits Provider Recognized for Record Growth and Technological Innovation for Second Consecutive Year
NEW YORK, November 21, 2024 – Kindbody, the leading national fertility clinic network and global family-building benefits provider for employers, today announced it ranked No. 72 on the Deloitte Technology Fast 500™, which recognizes the fastest growing and most innovative technology companies in North America. Kindbody grew 1,910% during the period of 2020 to 2023 due to the growing demand for fertility and family-building care from employers and patients nationwide. Kindbody has ranked within the top 100 on the Deloitte Technology Fast 500 list for two consecutive years.
“We are incredibly honored to be recognized by Deloitte and to stand alongside some of the world’s most groundbreaking companies,” said Scott Bruckner, Chief Financial Officer of Kindbody. “This award is a reflection of our rapid growth, the dedication of our exceptional team, the invaluable partnerships with our employer clients, and the critical importance of making fertility and family-building care accessible and affordable for everyone, now and in the future.”
Since 2018, Kindbody has led the reproductive healthcare industry for its significant technology investments. The company’s initial seed capital acquired the foundational code for KindEMR. Fertility is highly predictable and the objective was to replace anecdotal decision-making with predictive technology.
Kindbody’s Chief Technology Officer Richard Forsythe said, “Receiving this esteemed award is a remarkable achievement for our team. This recognition is a testament to our team’s relentless commitment to innovation and reflects our continuous investment in advancing technology to better support our physicians and improve patient outcomes.”
Kindbody’s proprietary technology is centered on its HIPAA-compliant electronic medical record (KindEMR) for increased standardization of care, offering online scheduling for virtual and in-person appointments and an intuitive patient portal. The KindEMR supports the full spectrum of reproductive health and family-building care including both female and male fertility, fertility preservation, genetic testing, in vitro fertilization (IVF), donor and surrogacy services, and adoption. Additionally, Kindbody has invested heavily to improve artificial intelligence (AI) in fertility treatment. The Company is working on several AI products including: a more personalized, standardized decision making tool allowing for more efficiency for the provider; an improved prognosis tool so the patient knows what to expect and predicts their likelihood of success; and AI in the lab to better predict which embryo is best to transfer and which egg is best to fertilize.
About the 2024 Deloitte Technology Fast 500
Now in its 30th year, the Deloitte Technology Fast 500 provides a ranking of the fastest-growing
technology, media, telecommunications, life sciences, fintech, and energy tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2021 to 2024. In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues. Companies must have base-year operating revenues of at least US$50,000, and current-year operating revenues of at least US$5 million. Additionally, companies must be in business for a minimum of four years and be headquartered within North America.
About Kindbody
Kindbody is the leading U.S. fertility clinic network and global family-building benefits provider for employers on a mission to make fertility care more affordable and accessible for all. Kindbody serves patients at 35+ state-of-the-art signature clinics and IVF labs, 400+ partner clinics, and in 113 countries around the world. Trusted by more than 133 employers, Kindbody’s physician-led model covers the full-spectrum of reproductive healthcare including fertility assessments, fertility preservation, genetic testing, IVF, donor and surrogacy services, adoption, postpartum care, and menopause support. Kindbody is the only fertility benefits provider that serves patients directly, delivering a seamless, integrated experience with superior health outcomes at lower cost. Recognized for technology innovation and industry leadership, Kindbody has been named to CNBC Disruptor 50, Fast Company’s Brands that Matter, Forbes Best Startup Employers, Inc.’s Best In Business list of most admired companies, as well as Deloitte Technology Fast 500™, which recognizes the fastest growing and most innovative technology companies in North America. Founded in 2018, Kindbody has raised more than $315 million in debt and equity funding from leading investors including Perceptive Advisors, JP Morgan Chase’s Morgan Health, GV, RRE Ventures, Claritas Health Ventures, Rock Springs Capital, Distributed Ventures, Whatif Ventures and TQ Ventures. Visit www.kindbody.com. and follow us on Instagram and Linkedin.
About Deloitte
Deloitte provides industry-leading audit, consulting, tax and advisory services to many of the world’s most admired brands, including nearly 90% of the Fortune 500® and more than 8,500 U.S.-based private companies. At Deloitte, we strive to live our purpose of making an impact that matters by creating trust and confidence in a more equitable society. We leverage our unique blend of business acumen, command of technology, and strategic technology alliances to advise our clients across industries as they build their future. Deloitte is proud to be part of the largest global professional services network serving our clients in the markets that are most important to them. Bringing more than 175 years of service, our network of member firms spans more than 150 countries and territories. Learn how Deloitte’s approximately 460,000 people worldwide connect for impact at www.deloitte.com.
# # #
